Ascendis Pharma A/S (ASND)

209.63 -1.39 (-0.66%) USD  |  NASDAQ  |  Dec 30, 13:44
More

Ascendis Pharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Evaxion AS Upgrade
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Akari Therapeutics Plc Upgrade